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ABSTRACT 
Preliposomes are a novel drug delivery system (NDDS). Preliposomes, due to their various forms, require further exploration. These structures 
can deliver both hydrophilic and hydrophobic drugs for cancer, bacterial infections, fungal infections, immunomodulation, diagnostics, 
ophthalmic, vaccines, enzymes and genetic elements. Prevesicular drug delivery system like preliposomes having distinct advantages over 
conventional drug delivery system. These systems overcome the problems associated with instability of liposomes. preliposomes composed of 
water-soluble porous powder as carrier which having ability to rapid hydration of preliposomes and formed vesicles. New concept of 
demonstrating preliposomes as novel carrier to enhance the oral bioavailability and permeation across the membrane. On the basis of 
investigation. it is clear that pre-liposomes are the alternate drug carrier for the various route of administration. These reviews give the brief 
knowledge about the preparation, evaluation and application of prevesicular drug delivery system in pharmaceutical field. The current 
deepening and widening of liposome interest in many scientific disciplines and their application in pharmaceutics, cosmetics and food industries 
as promising novel breakthroughs and products are also handle. The obtained information allows establishing criteria for selecting pre-
liposomes as a drug carrier according to its advantages and limitations.  
Keywords: Novel drug delivery, Liposomes, Lamellar, Carrier 
 
 Article Info: Received 20 Feb 2019;     Review Completed 23 March 2019;     Accepted 26 March 2019;     Available online 15 April 2019 
Cite this article as: 
Sheth M, Jadhav D, Jain H, Meshram DB, Pre-Liposomes: A novel drug delivery system, Journal of Drug Delivery and 
Therapeutics. 2019; 9(2-s):525-528    http://dx.doi.org/10.22270/jddt.v9i2-s.2613                                           
*Address for Correspondence:  




Preliposomes are defined as an artificial microscopic vesicle 
consisting of a central aqueous compartment surrounded by 
one or more concentric phospholipid. Structurally liposomes 
contain phospholipids which are biocompatible, 
biodegradable, nontoxic and not having any allergic or 
pyrogenic reactions. 1 Preliposomes have been extensively 
use for the site-specific drug delivery, increased solubility, 
controlled release, sustained release, prevent the drug 
degradation for the drug. which are affected by the gastric 
pH. Preliposomes are dry, phospholipids which, upon 
addition of water, disperse to form a multi-lamellar 
liposomal suspension. Preliposomes having the intrinsic 
property of hydration in which lipids membrane formed the 
vesicles when contact with aqueous media. 2 Preliposomes 
available in the dry powder form, easy to distribute, transfer, 
measure and store making it a versatile system. 
Preliposomes are given in the form of dry powder for 
pulmonary drug delivery, tablet, and capsule for oral, buccal, 
and rectal route. Preliposomes enhanced the oral 
bioavailability of drug which are poorly water soluble and 
having the extensive first pass metabolism. 3 
ADVANTAGES OF PRELIPOSOMES 
o Preliposomes are more stable then liposomes.   
o High entrapment of hydrophilic material.  
o Therapeutic benefits of preliposomes include enhanced 
bioavailability. 
o Protection of drugs from degradation in the GIT.  
o Reduced toxicity and taste masking.4 
o Preliposomes relatively cheap as compare to liposomes. 4 
o Convenient to prepare. 
o The preliposomes used for targeted drug delivery and 
controlled drug release. 
o Targeting of anti-cancer drugs to tumour sites. 
o Targeting of drugs to non-Reticular endothelial tissues, 
which has not been possible with conventional 
liposomes. 
o Preliposomes can use for controlling release within the 
vasculature by manipulating the phospholipid 
composition of bi-layers.5 
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Figure 1: Liposomes classification based on size and lamellarity 
 
METHODS  
Film-deposition on carrier method. 
It involves   deposition of film of drugs and phospholipids 
onto a porous, water soluble carrier material. Solution of 
drug and phospholipids in a volatile organic solvent is 
introduced drop wise via feed tube onto a bed of carrier 
material held in a flask of a rotary flash evaporator under 
vacuum. At any given time, over-wetting of the matrix is 
avoided and subsequent aliquot of organic solution is 
introduced only when a free-flowing powder matrix is 
obtained. It also enables high surfactant to carrier mass ratio 
in the preparation of preliposomes. Further, being water 
soluble they allow rapid formation of liposomal dispersion 
on hydration and by controlling the size of porous powder, 
relatively narrow range of reconstituted liposomes can be 
obtained. E.g., maltodextrin, sorbitol, microcrystalline 
cellulose, magnesium aluminium silicates, Mannitol, etc.6 
 
 
Figure 2: Film Deposition on carrier method 
 
Spray drying method 
This method is mainly used when particles of uniform size 
and shape are required and can be easily scaled up it is cost 
effective and suitable for large scale production of 
preliposomes. The unique feature of spray drying process 
lies in its ability to involve both particle formation and 
drying in a continuous single step, allowing better control of 
particle. Spray drying is not only limited to aqueous 
solutions, but can also be used for non-aqueous systems to 
prepare particles.  
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The spray drying process involves four stages.7 
 Atomization of the product into a spray nozzle. 
 Spray-air contact. 
 Drying of the spray droplets, and  
 Collection of the solid product. 
 
Figure 3: Spray drying method 
 
Fluidized-bed method. 
It works on the principle of particle coating technology. The 
carrier material used here can vary from crystalline powder 
to non-pareil beads. When using beads as carrier material, 
initial seal coating is applied to the beads to provide a 
smooth surface for further coating of phospholipids. This 
ensures formation of thin uniform coating of phospholipid 
around the core and formation of smaller sized liposomes 
upon hydration.8 
 
Figure 4: Fluidized-bed method 
CHARACTERIZATION OF PRELIPOSOMES 
Scanning Electron Microscopy (SEM) 
SEM is mainly used to view the surface morphology of the 
Preliposomes powder. This involves comparing the image of 
the pure carrier material with that of the Preliposomes. The 
illegibility of the image of the carrier material in the 
formulation confirms the deposition of phospholipid on the 
carrier and thus confirming the formation of preliposomes.8 
Transmission Electron Microscopy (TEM) 
TEM is mainly used to study the morphology of the 
liposomes from preliposomes upon hydration and observing 
the shape and lamellarity of the liposome vesicles formed 
under the microscope.8 
Hydration study 
Hydration study is carried out on the fact that liposomes are 
formed on contact with aqueous environment. In this 
method we place small quantity of dry powder of pro-
liposomes and place it on a glass slide and then gradual 
addition of water in it and it can observe by using 
microscope to view vesicle formation. During hydration 
dissolution and disintegration occur rapidly as soon as 
hydration.9 
Differential Scanning Calorimetry (DSC) 
The calorimetric analysis is performed in order to determine 
the differences in properties of lecithin and cholesterol 
previously structured in the preliposomes and the effect of 
the drug on these properties.9 
 Zeta Potential 
The zeta Potential is defined as the difference in potential 
between the surface of the tightly bound layer (shear plane) 
and the electro-neutral region of the solution. This can be 
used to study the surface charge of the particles. The zeta 
potential of samples is measured using Zetasizer 3000 HS. 
Flow Property 
It ensures the despite the deposition of phospholipids on 
carriers, the flow ability of particles is not affected. This can 
be done by measuring the parameters such as Angle of 
Repose, Carr’s Index or Compressibility Index and Hauser’s 
Ratio. 
Drug Entrapment Studies 
Separation of unentrapped drug can be done by mini column 
centrifugation method. Liposomal suspension can be 
centrifuged at 2000 rpm for 3 min. Elutes containing drug 
loaded liposomes can collected and can be observed under 
optical microscope to ensure the absence of unentrapped 
drug particles. Appropriate amount of elute can be digested 
with chloroform methanol and the clear solution be obtained 
and analysed by spectrophotometrically.10 
In Vitro Dissolution Study 
In vitro dissolution study of preliposome powder can be 
performed by USP Dissolution apparatus Type II and Franz 
diffusion cell using any suitable membrane such as rat skin, 
cellophane dialysis membrane.10 
APPLICATION 11-12 
1) As a parenteral delivery 
2) As a oral delivery 
3) For the treatment of Arthritis 
4) As a dry powder inhalers (DPIs) 
5) As a nebulizer 
6) As a transdermal delivery 
7) As a mucosal deliver 
Sheth et al                                                                                                               Journal of Drug Delivery & Therapeutics. 2019; 9(2-s):525-528 
ISSN: 2250-1177                                                                                  [528]                                                                                 CODEN (USA): JDDTAO 
CONCLUSION 
Preliposomes are novel vesicular carrier having ability to 
overcome the instability issue associated with the vesicular 
drug delivery system. To develop a prevesicular drug 
delivery system for the challenging drug for large scale-up 
and controlled release of the encapsulated drug. Utilising 
methods such as spray drying and fluidised bed drying 
preliposomes can be produced on a large scale. They also 
have the ability to be delivered as conventional formulations 
the preliposomes are administrated orally, parenterally and 
topically as well as used in cosmetic and hair technologies, 
sustained release formulations, diagnostic purpose and as 
good carriers in gene delivery.  
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